BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22547545)

  • 1. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
    McPhee JB; Mena P; Zhang Y; Bliska JB
    Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence.
    McPhee JB; Mena P; Bliska JB
    Infect Immun; 2010 Aug; 78(8):3529-39. PubMed ID: 20515922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.
    Chung LK; Park YH; Zheng Y; Brodsky IE; Hearing P; Kastner DL; Chae JJ; Bliska JB
    Cell Host Microbe; 2016 Sep; 20(3):296-306. PubMed ID: 27569559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence.
    McCoy MW; Marré ML; Lesser CF; Mecsas J
    Infect Immun; 2010 Jun; 78(6):2584-98. PubMed ID: 20368345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
    Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
    Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
    Monnazzi LG; Carlos IZ; de Medeiros BM
    Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.
    Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
    Infect Immun; 2004 Aug; 72(8):4589-602. PubMed ID: 15271919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10.
    Auerbuch V; Isberg RR
    Infect Immun; 2007 Jul; 75(7):3561-70. PubMed ID: 17420232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues.
    Logsdon LK; Mecsas J
    Infect Immun; 2003 Aug; 71(8):4595-607. PubMed ID: 12874339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.
    Miller HK; Kwuan L; Schwiesow L; Bernick DL; Mettert E; Ramirez HA; Ragle JM; Chan PP; Kiley PJ; Lowe TM; Auerbuch V
    PLoS Pathog; 2014 Jun; 10(6):e1004194. PubMed ID: 24945271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of a novel Toll/interleukin-1 receptor (TIR)-domain containing virulence protein of Y. pseudotuberculosis among Far East scarlet-like fever serotype I strains.
    Nörenberg D; Wieser A; Magistro G; Hoffmann C; Meyer C; Messerer M; Schubert S
    Int J Med Microbiol; 2013 Dec; 303(8):583-94. PubMed ID: 24018301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-3 mediates the pathogenic effect of Yersinia pestis YopM in liver of C57BL/6 mice and contributes to YopM's function in spleen.
    Ye Z; Gorman AA; Uittenbogaard AM; Myers-Morales T; Kaplan AM; Cohen DA; Straley SC
    PLoS One; 2014; 9(11):e110956. PubMed ID: 25372388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
    Fisher ML; Castillo C; Mecsas J
    Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulation of Interleukin-1β and Interleukin-18 Production by Yersinia pestis Effectors YopJ and YopM and Redundant Impact on Virulence.
    Ratner D; Orning MP; Starheim KK; Marty-Roix R; Proulx MK; Goguen JD; Lien E
    J Biol Chem; 2016 May; 291(19):9894-905. PubMed ID: 26884330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered frameshifted YopN-TyeA chimeras influence type III secretion system function in Yersinia pseudotuberculosis.
    Amer AA; Costa TR; Farag SI; Avican U; Forsberg Å; Francis MS
    PLoS One; 2013; 8(10):e77767. PubMed ID: 24098594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.
    Bozue J; Mou S; Moody KL; Cote CK; Trevino S; Fritz D; Worsham P
    Microb Pathog; 2011 Jun; 50(6):314-21. PubMed ID: 21320584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a molecular pathogenic pathway for Yersinia pestis YopM.
    Uittenbogaard AM; Chelvarajan RL; Myers-Morales T; Gorman AA; Brickey WJ; Ye Z; Kaplan AM; Cohen DA; Ting JP; Straley SC
    Front Cell Infect Microbiol; 2012; 2():155. PubMed ID: 23248776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced secretion of YopJ by Yersinia limits in vivo cell death but enhances bacterial virulence.
    Brodsky IE; Medzhitov R
    PLoS Pathog; 2008 May; 4(5):e1000067. PubMed ID: 18483548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
    Logsdon LK; Mecsas J
    Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.